Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Non Operating Income: 2014-2025

Historic Non Operating Income for Fortress Biotech (FBIO) over the last 12 years, with Sep 2025 value amounting to $17.7 million.

  • Fortress Biotech's Non Operating Income rose 490.11% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year increase of 323.19%. This contributed to the annual value of -$10.2 million for FY2024, which is 9.98% up from last year.
  • As of Q3 2025, Fortress Biotech's Non Operating Income stood at $17.7 million, which was down 28.80% from $24.8 million recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Non Operating Income peaked at $24.8 million during Q2 2025, and registered a low of -$9.2 million during Q2 2023.
  • Moreover, its 3-year median value for Non Operating Income was -$2.1 million (2024), whereas its average is $1.7 million.
  • In the last 5 years, Fortress Biotech's Non Operating Income crashed by 280.65% in 2023 and then soared by 2,495.66% in 2025.
  • Fortress Biotech's Non Operating Income (Quarterly) stood at -$6.0 million in 2021, then spiked by 60.86% to -$2.4 million in 2022, then plummeted by 280.65% to -$9.0 million in 2023, then skyrocketed by 76.15% to -$2.1 million in 2024, then spiked by 490.11% to $17.7 million in 2025.
  • Its Non Operating Income was $17.7 million in Q3 2025, compared to $24.8 million in Q2 2025 and -$2.4 million in Q1 2025.